Analyst Price Targets — NKTX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 18, 2026 12:38 pm | — | Evercore ISI | $9.00 | $2.68 | TheFly | Nkarta price target lowered to $9 from $25 at Evercore ISI |
| March 26, 2024 6:47 am | Bill Maughan | Canaccord Genuity | $16.00 | $9.61 | StreetInsider | Nkarta Inc. (NKTX) PT Raised to $16 at Canaccord Genuity |
| March 22, 2024 8:17 am | Gil Blum | Needham | $15.00 | $12.98 | Benzinga | These Analysts Revise Their Forecasts On Nkarta After Q4 Results |
| March 22, 2024 6:35 am | Salim Syed | Mizuho Securities | $25.00 | $8.92 | StreetInsider | Nkarta Inc. (NKTX) PT Lowered to $25 at Mizuho on deprioritization of NKX101 |
| March 22, 2024 3:34 am | Laura Prendergast | Raymond James | $16.00 | $8.92 | StreetInsider | Raymond James Downgrades Nkarta Inc. (NKTX) to Outperform |
| April 26, 2022 4:23 am | — | Raymond James | $32.00 | $18.72 | Benzinga | Raymond James Maintains Outperform on Nkarta, Raises Price Target to $32 |
| April 26, 2022 4:19 am | — | H.C. Wainwright | $36.00 | $18.72 | Benzinga | HC Wainwright & Co. Maintains Buy on Nkarta, Raises Price Target to $36 |
Latest News for NKTX
At 2 p.m. ET on Tuesday, June 30th, Nkarta President Nadir Mahmood will take part in a fireside at the H.C. Wainwright Cell Therapy Virtual Conference.
/PRNewswire/ -- USA News Group Market Commentary - Start with the number that makes everyone do a double take. As of mid-May 2026, GT Biopharma (NASDAQ: GTBP)
Enrollment ongoing at 4 billion cell dose level (12 billion cells in 3-dose cycle) across all indications in Ntrust-1 and Ntrust-2 Regulatory agreement supports expansion into community-based settings with outpatient dosing to reduce patient burden Initial clinical data from Ntrust-1 and Ntrust-2 expected to be presented at a medical meeting in 2026 Cash balance of $266.7 million on March 31, 2026, including cash,…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NKTX.
U.S. House Trading
No House trades found for NKTX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.